• HPLC analyses 8-oxodG in oesophageal cancer patients
    Oesophageal cancer patients have been studied using HPLC

    HPLC, UHPLC

    HPLC analyses 8-oxodG in oesophageal cancer patients

    Findings published in the Journal of Experimental & Clinical Cancer Research report the results of high performance liquid chromatography (HPLC) analysis of levels of 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxodG) in a cohort of oesophageal cancer patients.

    The study was an attempt to determine how 8-oxodG levels are related to genetic susceptibility and antioxidant vitamin presence as part of an investigation into elevated oxidative stress seen in previous research.

    HPLC with electrochemical detection allowed for 8-oxodG in peripheral blood mononuclear cells to be identified and analysed alongside genetic tests and vitamin measurements.

    The scientists report that they were unable to prove a statistically significant connection between vitamin levels in serum, genetic polymorphisms and the 8-oxodG levels in their cancerous and control participants.

    Studies disseminated in the Journal of Experimental & Clinical Cancer Research cover all aspects of oncology, with the aim of creating a high-quality discussion platform for basic, translational and clinical cancer analysis.

    Events

    SETAC Europe

    May 11 2025 Vienna, Austria

    MSB 2025

    May 18 2025 Tempe. AZ, USA

    ChemUK 2025

    May 21 2025 Birmingham, UK

    ASMS Conference

    Jun 01 2025 Baltimore, MD, USA

    HPLC 2025

    Jun 15 2025 Bruges, Belgium

    View all events

    Great Job...
    The latest issue will be with you shortly
    Sign up to Chromatography Today for FREE.
    Register and get the eBulletin, a Monthly email packed with the latest Chromatography products, news and services. Join us and get the latest information first.